e-learning
resources
Virtual 2020
Pre-Congress Content
Prediction of outcomes in obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease
C. Rhee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), K. Jung (Anyang, Republic of Korea)
Source:
Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Session:
Prediction of outcomes in obstructive diseases
Session type:
E-poster session
Number:
960
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Rhee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), K. Jung (Anyang, Republic of Korea). High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease. 960
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Determinants of depression at exacerbation in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003
Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease.
Source: International Congress 2017 – COPD and weaning
Year: 2017
Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
IL-8 in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 364s
Year: 2001
Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011
Chronic pain in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease?
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 576s
Year: 2006
Regulation of ghrelin on appetite in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Mortality in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001
Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept